| 英文摘要 |
Adjuvant chemotherapy has been proven to improve the survival rate in patients with early stage non-small cell lung cancer. We reviewed the patients with stage I-IIIA non-small cell lung cancer in 2012. There were a total of 50 patients with stage I-IIIA patients who had received the operation. Among them, only 20 (40%) had received adjuvant chemotherapy. The major reasons for patients not receiving adjuvant chemotherapy were: unclear guidelines regarding adjuvant chemotherapy, poor communications among physicians, lack of an education program regarding adjuvant chemotherapy for patients, lack of educational sheets regarding adjuvant chemotherapy for patients. To improve patients with early (I-IIIA) stage non-small cell lung cancer receiving adjuvant chemotherapy, we amended the guidance of the adjuvant therapy after operation, established the caring protocols, such as proposal conferences by cancer collaboration teams, elaborated the roles and functions of care-managers, and provided nursing care for adjuvant therapy post-operation. After these interventions, 17 of 23 (74%) patients with early (I-IIIA) stage patients who received operation between January 2013 and August 2013 received adjuvant chemotherapy. The cooperation among professional team members provides patients with best treatment modalities that could improve overall survival rate. |
